News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,753 Results
Type
Article (45980)
Company Profile (334)
Press Release (708415)
Multimedia
Podcasts (154)
Webinars (25)
Section
Business (213077)
Career Advice (2223)
Deals (37286)
Drug Delivery (144)
Drug Development (84715)
Employer Resources (178)
FDA (17049)
Job Trends (15701)
News (361695)
Policy (34680)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2666)
Accelerated approval (43)
Adcomms (34)
Allergies (169)
Alliances (52233)
ALS (201)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (397)
Approvals (17340)
Artificial intelligence (634)
Autoimmune disease (233)
Automation (50)
Bankruptcy (379)
Best Places to Work (11842)
BIOSECURE Act (22)
Biosimilars (214)
Biotechnology (195)
Bladder cancer (178)
Brain cancer (67)
Breast cancer (702)
Cancer (5461)
Cardiovascular disease (479)
Career advice (1880)
Career pathing (44)
CAR-T (311)
CDC (61)
Celiac Disease (2)
Cell therapy (835)
Cervical cancer (41)
Clinical research (72816)
Collaboration (1997)
Company closure (5)
Compensation (1300)
Complete response letters (83)
COVID-19 (2824)
CRISPR (106)
C-suite (1015)
Cystic fibrosis (154)
Data (7127)
Decentralized trials (3)
Denatured (44)
Depression (160)
Dermatology (58)
Diabetes (571)
Diagnostics (6945)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (309)
Drug pricing (229)
Drug shortages (35)
Duchenne muscular dystrophy (273)
Earnings (93271)
Editorial (66)
Employer branding (21)
Employer resources (158)
Events (122602)
Executive appointments (1069)
FDA (20524)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1650)
Gene editing (224)
Generative AI (58)
Gene therapy (692)
GLP-1 (1137)
Government (4927)
Grass and pollen (7)
Guidances (398)
Healthcare (19260)
HIV (75)
Huntington's disease (53)
IgA nephropathy (95)
Immunology and inflammation (306)
Immuno-oncology (87)
Indications (158)
Infectious disease (3151)
Inflammatory bowel disease (211)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (278)
Interviews (347)
IPO (17098)
IRA (58)
Job creations (4180)
Job search strategy (1577)
JPM (71)
Kidney cancer (19)
Labor market (93)
Layoffs (609)
Leadership (42)
Legal (8583)
Liver cancer (100)
Longevity (29)
Lung cancer (733)
Lymphoma (412)
Machine learning (53)
Management (62)
Manufacturing (965)
MASH (188)
Medical device (13990)
Medtech (14067)
Mergers & acquisitions (21354)
Metabolic disorders (1531)
mRNA (188)
Multiple sclerosis (179)
NASH (21)
Neurodegenerative disease (403)
Neuropsychiatric disorders (108)
Neuroscience (3233)
Neurotech (1)
NextGen: Class of 2026 (6743)
Non-profit (4605)
Now hiring (73)
Obesity (749)
Opinion (323)
Ovarian cancer (187)
Pain (247)
Pancreatic cancer (256)
Parkinson's disease (348)
Partnered (34)
Patents (566)
Patient recruitment (602)
Peanut (64)
People (61825)
Pharmaceutical (95)
Pharmacy benefit managers (36)
Phase 1 (22708)
Phase 2 (31975)
Phase 3 (23937)
Pipeline (7203)
Policy (335)
Postmarket research (2687)
Preclinical (9573)
Press Release (68)
Prostate cancer (280)
Psychedelics (52)
Radiopharmaceuticals (313)
Rare diseases (1052)
Real estate (6422)
Recruiting (72)
Regulatory (26253)
Reports (54)
Research institute (2480)
Resumes & cover letters (376)
Rett syndrome (32)
RNA editing (19)
RSV (93)
Schizophrenia (173)
Series A (275)
Series B (206)
Service/supplier (14)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (171)
Sponsored (46)
Startups (3846)
State (2)
Stomach cancer (20)
Supply chain (124)
Tariffs (101)
The Weekly (107)
Vaccines (1112)
Venture capital (105)
Weight loss (508)
Women's health (112)
Worklife (20)
Date
Last 7 days (651)
Last 30 days (2504)
Last 365 days (30752)
2026 (8220)
2025 (31087)
2024 (36142)
2023 (40932)
2022 (52117)
2021 (56677)
2020 (55119)
2019 (47835)
2018 (36150)
2017 (33576)
2016 (33184)
2015 (39019)
2014 (32966)
2013 (28082)
2012 (30168)
2011 (30877)
2010 (28894)
Location
Africa (835)
Alabama (91)
Alaska (7)
Arizona (340)
Arkansas (15)
Asia (43413)
Australia (6897)
California (12372)
Canada (3546)
China (1291)
Colorado (528)
Connecticut (525)
Delaware (373)
Europe (93676)
Florida (1884)
Georgia (394)
Hawaii (3)
Idaho (62)
Illinois (978)
India (83)
Indiana (574)
Iowa (22)
Japan (502)
Kansas (130)
Kentucky (44)
Louisiana (40)
Maine (73)
Maryland (1504)
Massachusetts (8885)
Michigan (350)
Minnesota (681)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (82)
New Jersey (3318)
New Mexico (31)
New York (3268)
North Carolina (1624)
North Dakota (9)
Northern California (6101)
Ohio (371)
Oklahoma (23)
Oregon (47)
Pennsylvania (2509)
Puerto Rico (27)
Rhode Island (50)
South America (1204)
South Carolina (77)
South Dakota (1)
Southern California (4857)
Tennessee (202)
Texas (1953)
United States (44047)
Utah (372)
Vermont (1)
Virginia (309)
Washington D.C. (81)
Washington State (993)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
754,753 Results for "circle pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Circle Pharma to Present New Clinical and Preclinical Data at AACR 2026
March 18, 2026
·
3 min read
Press Releases
Circle Pharma to Participate in Upcoming Investor Conferences
February 17, 2026
·
1 min read
Press Releases
Circle Pharma Announces Publication in Journal of Medicinal Chemistry Highlighting Optimization of First-in-Class Oral Cyclin A/B RxL Inhibitors
March 12, 2026
·
2 min read
Press Releases
Circle Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
November 3, 2025
·
2 min read
Press Releases
Circle Pharma Appoints Anne E. Borgman, M.D., as Chief Medical Officer
December 2, 2025
·
3 min read
Press Releases
Circle Pharma Announces Participation in Upcoming November 2025 Investor Conferences
November 5, 2025
·
1 min read
Press Releases
Circle Pharma to Participate in Upcoming September 2025 Investor Conferences
September 3, 2025
·
1 min read
Circle Pharma Announces Nomination of CID-165, an Oral First-in-class Cyclin D1 RxL Inhibitor, as Development Candidate for its Second Oncology Program
December 18, 2025
·
2 min read
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. in alignment with Trump’s Most Favored Nation policy, patients will suffer.
April 2, 2026
·
3 min read
·
Annalee Armstrong
1 of 75,476
Next
